Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Shandong Boan Biotechnology Company., Limited. Class H ( (HK:6955) ) has shared an update.
Shandong Boan Biotechnology Co., Ltd. has completed the placement of 48 million new shares, representing 7.71% of its total issued shares, at a price of HK$16.42 per share. The proceeds from this placement are intended to support the company’s research and development, commercialization activities, and working capital needs, as it seeks to accelerate its pipeline and maintain competitiveness in the biopharmaceutical sector.
More about Shandong Boan Biotechnology Company., Limited. Class H
Shandong Boan Biotechnology Co., Ltd. is a biopharmaceutical company based in China, focusing on the research, development, and commercialization of innovative product candidates. The company is active in the biotechnology industry, with a market focus on developing treatments involving antibodies and other advanced therapeutic modalities.
Average Trading Volume: 24,322,065
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.92B
For detailed information about 6955 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money